Through the late 1960’s, certain psychedelic treatments were legal. In the 1970’s,
as a response to the stigmatization of recreational use, psychedelics became
classified as a Schedule I narcotic and were therefore illegal.
Despite the fact that psychedelics are illegal, the last decade has seen an explosion of research showing clinical benefits,
with results so intriguing that governments are greenlighting
studies and approvals around the world.
As a result of the increase in research from non-commercial entities to revisit
psychedelic use for mental health, psychedelic assisted therapies
were granted “Break Through” status by the FDA in 2018.
With the change in status, there has been a
renaissance of research
into the role of LSD,
psilocybin (aka “magic mushrooms”),
MDMA (aka “ecstasy”), DMT (aka “ ayahuasca ”),
ketamine and other psychedelic substances
depression, PTSD, addiction,
and other forms of mental illness.